tiprankstipranks
Apotex Health Corp. (TSE:APTX)
TSX:APTX
Canadian Market
Want to see TSE:APTX full AI Analyst Report?

Apotex Health Corp. (APTX) Stock Forecast & Price Target

28 Followers
See the Price Targets and Ratings of:

APTX Analyst Ratings

Strong Buy
12Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Apotex
Health Corp.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

APTX Stock 12 Month Forecast

Average Price Target

C$40.75
▲(22.93% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Apotex Health Corp. in the last 3 months. The average price target is C$40.75 with a high forecast of C$43.00 and a low forecast of C$36.00. The average price target represents a 22.93% change from the last price of C$33.15.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"C$26","35":"C$35","44":"C$44","30.5":"C$30.5","39.5":"C$39.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$43.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$40.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$36.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[26,30.5,35,39.5,44],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,33.15,33.90769230769231,34.66538461538462,35.42307692307692,36.18076923076923,36.93846153846154,37.69615384615385,38.45384615384615,39.21153846153846,39.96923076923077,40.72692307692308,41.48461538461538,42.24230769230769,{"y":43,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,33.15,33.73461538461538,34.31923076923077,34.90384615384615,35.488461538461536,36.073076923076925,36.65769230769231,37.24230769230769,37.82692307692308,38.41153846153846,38.996153846153845,39.580769230769235,40.16538461538462,{"y":40.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,33.15,33.36923076923077,33.58846153846154,33.80769230769231,34.026923076923076,34.246153846153845,34.465384615384615,34.684615384615384,34.90384615384615,35.12307692307692,35.34230769230769,35.56153846153846,35.78076923076923,{"y":36,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":32.28,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.6,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.15,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetC$43.00Average Price TargetC$40.75Lowest Price TargetC$36.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bloom Burton Analyst forecast on TSE:APTX
Bloom Burton
Bloom Burton
C$40
Buy
20.66%
Upside
Reiterated
08/13/26
Apotex Health Corp.: Buy Rating Reiterated as Strong Q1 FY2027 Results Support Unchanged $40 Price Target
CIBC
C$40
Buy
20.66%
Upside
Reiterated
08/13/26
Apotex Health Corp. (APTX) Gets a Buy from CIBC
Stifel Nicolaus Analyst forecast on TSE:APTX
Stifel Nicolaus
Stifel Nicolaus
C$42
Buy
26.70%
Upside
Reiterated
08/13/26
Stifel Nicolaus Reaffirms Their Buy Rating on Apotex Health Corp. (APTX)
BMO Capital Analyst forecast on TSE:APTX
BMO Capital
BMO Capital
C$39C$43
Buy
29.71%
Upside
Reiterated
08/12/26
Apotex Health Corp. (APTX) Receives a Buy from BMO Capital
RBC Capital Analyst forecast on TSE:APTX
RBC Capital
RBC Capital
C$43
Buy
29.71%
Upside
Reiterated
08/12/26
RBC Capital Keeps Their Buy Rating on Apotex Health Corp. (APTX)
Canaccord Genuity Analyst forecast on TSE:APTX
Canaccord Genuity
Canaccord Genuity
C$42
Buy
26.70%
Upside
Initiated
07/13/26
Apotex Health initiated with a Buy at CanaccordApotex Health initiated with a Buy at Canaccord
Desjardins Analyst forecast on TSE:APTX
Desjardins
Desjardins
C$40
Buy
20.66%
Upside
Initiated
07/06/26
Apotex Health initiated with a Buy at DesjardinsApotex Health initiated with a Buy at Desjardins
Scotiabank Analyst forecast on TSE:APTX
Scotiabank
Scotiabank
C$40
Buy
20.66%
Upside
Initiated
07/06/26
Apotex Health initiated with an Outperform at ScotiabankApotex Health initiated with an Outperform at Scotiabank
Jefferies Analyst forecast on TSE:APTX
Jefferies
Jefferies
C$40
Buy
20.66%
Upside
Initiated
07/06/26
Apotex Health initiated with a Buy at JefferiesApotex Health initiated with a Buy at Jefferies
Raymond James Analyst forecast on TSE:APTX
Raymond James
Raymond James
C$36
Buy
8.60%
Upside
Initiated
07/06/26
Apotex Health initiated with an Outperform at Raymond JamesApotex Health initiated with an Outperform at Raymond James
National Bank Analyst forecast on TSE:APTX
National Bank
National Bank
C$43
Buy
29.71%
Upside
Initiated
07/06/26
Apotex Health initiated with an Outperform at National BankApotex Health initiated with an Outperform at National Bank
TD Cowen
C$33.95C$40
Buy
20.66%
Upside
Initiated
07/06/26
TD Cowen Initiates a Buy Rating on Apotex Health Corp. (APTX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bloom Burton Analyst forecast on TSE:APTX
Bloom Burton
Bloom Burton
C$40
Buy
20.66%
Upside
Reiterated
08/13/26
Apotex Health Corp.: Buy Rating Reiterated as Strong Q1 FY2027 Results Support Unchanged $40 Price Target
CIBC
C$40
Buy
20.66%
Upside
Reiterated
08/13/26
Apotex Health Corp. (APTX) Gets a Buy from CIBC
Stifel Nicolaus Analyst forecast on TSE:APTX
Stifel Nicolaus
Stifel Nicolaus
C$42
Buy
26.70%
Upside
Reiterated
08/13/26
Stifel Nicolaus Reaffirms Their Buy Rating on Apotex Health Corp. (APTX)
BMO Capital Analyst forecast on TSE:APTX
BMO Capital
BMO Capital
C$39C$43
Buy
29.71%
Upside
Reiterated
08/12/26
Apotex Health Corp. (APTX) Receives a Buy from BMO Capital
RBC Capital Analyst forecast on TSE:APTX
RBC Capital
RBC Capital
C$43
Buy
29.71%
Upside
Reiterated
08/12/26
RBC Capital Keeps Their Buy Rating on Apotex Health Corp. (APTX)
Canaccord Genuity Analyst forecast on TSE:APTX
Canaccord Genuity
Canaccord Genuity
C$42
Buy
26.70%
Upside
Initiated
07/13/26
Apotex Health initiated with a Buy at CanaccordApotex Health initiated with a Buy at Canaccord
Desjardins Analyst forecast on TSE:APTX
Desjardins
Desjardins
C$40
Buy
20.66%
Upside
Initiated
07/06/26
Apotex Health initiated with a Buy at DesjardinsApotex Health initiated with a Buy at Desjardins
Scotiabank Analyst forecast on TSE:APTX
Scotiabank
Scotiabank
C$40
Buy
20.66%
Upside
Initiated
07/06/26
Apotex Health initiated with an Outperform at ScotiabankApotex Health initiated with an Outperform at Scotiabank
Jefferies Analyst forecast on TSE:APTX
Jefferies
Jefferies
C$40
Buy
20.66%
Upside
Initiated
07/06/26
Apotex Health initiated with a Buy at JefferiesApotex Health initiated with a Buy at Jefferies
Raymond James Analyst forecast on TSE:APTX
Raymond James
Raymond James
C$36
Buy
8.60%
Upside
Initiated
07/06/26
Apotex Health initiated with an Outperform at Raymond JamesApotex Health initiated with an Outperform at Raymond James
National Bank Analyst forecast on TSE:APTX
National Bank
National Bank
C$43
Buy
29.71%
Upside
Initiated
07/06/26
Apotex Health initiated with an Outperform at National BankApotex Health initiated with an Outperform at National Bank
TD Cowen
C$33.95C$40
Buy
20.66%
Upside
Initiated
07/06/26
TD Cowen Initiates a Buy Rating on Apotex Health Corp. (APTX)
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Apotex Health Corp.

3 Months
David Martin PhDBloom Burton
Success Rate
0/2 ratings generated profit
0%
Average Return
-8.40%
Copying David Martin PhD's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -8.40% per trade.
1 Year
David Martin PhDBloom Burton
Success Rate
0/2 ratings generated profit
0%
Average Return
-8.40%
Copying David Martin PhD's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -8.40% per trade.
2 Years
David Martin PhDBloom Burton
Success Rate
0/2 ratings generated profit
0%
Average Return
-8.40%
Copying David Martin PhD's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -8.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

APTX Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
0
0
14
20
20
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
14
20
20
In the current month, APTX has received 20 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APTX average Analyst price target in the past 3 months is 40.75.
Each month's total comprises the sum of three months' worth of ratings.

APTX Financial Forecast

APTX Earnings Forecast

Next quarter’s earnings estimate for APTX is C$0.31 with a range of -C$0.02 to C$0.59. The previous quarter’s EPS was C$0.70. APTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year APTX has its overall industry.
Next quarter’s earnings estimate for APTX is C$0.31 with a range of -C$0.02 to C$0.59. The previous quarter’s EPS was C$0.70. APTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year APTX has its overall industry.

APTX Sales Forecast

Next quarter’s sales forecast for APTX is C$840.70M with a range of C$835.80M to C$853.10M. The previous quarter’s sales results were C$847.98M. APTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year APTX has its overall industry.
Next quarter’s sales forecast for APTX is C$840.70M with a range of C$835.80M to C$853.10M. The previous quarter’s sales results were C$847.98M. APTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year APTX has its overall industry.

APTX Stock Forecast FAQ

What is TSE:APTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Apotex Health Corp.’s 12-month average price target is 40.75.
    What is TSE:APTX’s upside potential, based on the analysts’ average price target?
    Apotex Health Corp. has 22.93% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TSE:APTX a Buy, Sell or Hold?
          Apotex Health Corp. has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Apotex Health Corp.’s price target?
            The average price target for Apotex Health Corp. is 40.75. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is C$43.00 ,the lowest forecast is C$36.00. The average price target represents 22.93% Increase from the current price of C$33.15.
              What do analysts say about Apotex Health Corp.?
              Apotex Health Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of TSE:APTX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.